Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 6/20 | 0.64 |
| ▸ | KISS1R | Q969F8 | 11/20 | 0.58 |
| ▸ | CTSL | P07711 | 1/20 | 0.53 |
| ▸ | CTSH | P09668 | 1/20 | 0.53 |
| ▸ | CTSS | P25774 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29420167 | 1.00 | MC4R (0.64) | MC4RKISS1RCTSLCTSHCTSS | |
| SCHEMBL30418415 | 0.94 | MC4R (0.58) | MC4RKISS1RCTSLCTSHCTSS | |
| SCHEMBL12094757 | 0.94 | MC4R (0.58) | MC4RKISS1RCTSLCTSHCTSS | |
| SCHEMBL12094755 | 0.94 | MC4R (0.58) | MC4RKISS1RCTSLCTSHCTSS | |
| SCHEMBL12094764 | 0.94 | MC4R (0.58) | MC4RKISS1RCTSLCTSHCTSS | |
| SCHEMBL12094797 | 0.94 | MC4R (0.58) | MC4RKISS1RCTSLCTSHCTSS | |
| SCHEMBL12094801 | 0.94 | MC4R (0.58) | MC4RKISS1RCTSLCTSHCTSS | |
| SCHEMBL29862114 | 0.94 | KISS1R (0.59) | MC4RKISS1R | |
| SCHEMBL29862312 | 0.94 | KISS1R (0.59) | MC4RKISS1R | |
| SCHEMBL29862360 | 0.94 | KISS1R (0.59) | MC4RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110319274-A1 | Identification of Compounds Modifying a Cellular Response | CARLSBERG A/S (DK) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319274-A1 | Identification of Compounds Modifying a Cellular Response | MYD88, CD14, STAT1 | MC4R 3747/4885KISS1R 4736/4885CTSL 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.